2-47403301-TCGACCGGGG-T
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PM4PP3
The NM_000251.3(MSH2):c.115_123delCGGGGCGAC(p.Arg39_Asp41del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R39R) has been classified as Likely benign.
Frequency
Consequence
NM_000251.3 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Lynch syndrome Uncertain:1
This sequence change deletes 9 nucleotides from exon 1 of the MSH2 mRNA (c.115_123del). This leads to the deletion of 3 amino acid residues in the MSH2 protein (p.Arg39_Asp41del) but otherwise preserves the integrity of the reading frame. This variant has not been published in the literature and is not present in population databases. The effect of a small in-frame deletion in this region of the MSH2 gene is unknown and experimental studies have not been done to assess the impact of this particular deletion on splicing or protein function. In summary, this is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This variant, c.115_123del, results in the deletion of 3 amino acid(s) of the MSH2 protein (p.Arg39_Asp41del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with colorectal cancer (internal data). ClinVar contains an entry for this variant (Variation ID: 216861). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.115_123delCGGGGCGAC (p.R39_D41DEL) alteration is located in exon 1 (coding exon 1) of the MSH2 gene. This alteration consists of an in-frame deletion of 9 nucleotides between nucleotide positions c.115 and c.123, resulting in the deletion of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at